低反应者何时应停止自体体外受精治疗
女性卵母细胞质量与数量随年龄下降是生殖成功的主要限制因素。年龄、卵巢储备、既往生育治疗结局及中心数据可用于预测体外受精的活产率。45岁后获得整倍体囊胚或活产的机会接近零,此年龄后使用自体卵母细胞的任何体外受精周期可视为徒劳并应劝阻。
要点
- 45岁后使用自体卵母细胞的体外受精周期可视为徒劳并应劝阻。
- 女性年龄之后,获卵数和可移植胚胎数是妊娠和活产的第二重要预测因素。
- ≤45岁患者是否尝试体外受精应结合年龄和预期卵巢反应给出推荐。
核心结论
- 45岁后使用自体卵母细胞的任何体外受精周期可视为徒劳并应劝阻。
- ≤45岁患者尝试体外受精的推荐应结合患者年龄和预期卵巢反应。
主要发现
- 45岁后获得整倍体囊胚或活产的机会接近零。
- 女性年龄之后,获卵数和可移植胚胎数是妊娠和活产的第二重要预测因素。
临床怎么用
- 体外受精周期开始前,必须向预后极差的患者充分告知预后、风险、费用及替代方案,包括使用供卵。
- 改善卵母细胞质量、减少非整倍体的替代治疗有可能改变临床医生对低反应者的处理,但这些治疗尚未准备好用于临床。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Declining oocyte quality and quantity with age are the main limiting factors in female reproductive success. Age of the female partner, ovarian reserve, the patient's previous fertility treatment outcomes, and the fertility center's pregnancy success data for specific patient profiles are used to predict live birth rates with in vitro fertilization (IVF) treatment. The chance of finding a euploid blastocyst or achieving live birth after the age of 45 is close to zero. Therefore, any IVF cycle using autologous oocytes after the age of 45 can be accepted as futile and should be discouraged. The number of mature eggs retrieved and the number of embryos available for transfer are the second most important predictors of pregnancy and live birth after female age. For patients aged ≤45 years, the recommendation for attempting IVF should be given considering the patient's age and the expected ovarian response. Before the start of the IVF cycle, patients with a very poor prognosis must be fully informed of the prognosis, risks, costs, and alternatives, including using donor oocytes. Alternative treatments to improve oocyte quality and decrease aneuploidy have the potential to change how clinicians treat poor responders. However, these treatments are not yet ready for clinical use.
引用
- Cakmak H. When is the right time to stop autologous in vitro fertilization treatment in poor responders? Fertil Steril. 2022. PMID: 35367012. doi:10.1016/j.fertnstert.2022.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。